Last updated: June 2026 · Reviewed June 2026 · Built by the InjectBuddy team
What is the difference between IM and SubQ injections? needle, site, volume and the draw
The difference between IM and SubQ is depth: an intramuscular injection delivers medication into muscle with a longer needle, while a subcutaneous injection deposits it into the fat layer just under the skin with a short needle. Both routes draw the exact same volume - the milliliters are set by your dose and the vial concentration, not by where the needle goes. This guide explains the key differences in needle, site, max volume and absorption speed, works through eight examples, and answers the most common questions.
- Same draw either way. Dose ÷ concentration sets your milliliters and U-100 units; the route does not.
- Needle differs. SubQ uses a short 4-8 mm needle; IM uses a longer 25-38 mm needle to reach muscle.
- Volume limits differ. SubQ comfortably holds about 1 mL per site; a large IM muscle accepts more.
- Absorption differs. Muscle is more vascular, so IM tends to absorb faster; SubQ is slower and steadier.
- Work the milliliters out, then sanity-check them in the Testosterone (TRT) dose calculator.
What IM and SubQ actually mean
Picture the tissue as layers. The skin sits on top, then a soft fat (subcutaneous) layer, then muscle underneath. A subcutaneous injection stops in the fat layer - like setting a marble into a shallow cushion - so it needs only a short needle angled at 45-90 degrees. An intramuscular injection has to pass through skin and fat to reach the muscle below, like pushing a peg through a cushion into the board behind it, so it uses a longer needle at 90 degrees.
Both routes share the same safety floor. Use a new sterile needle and syringe for every injection and never reuse a syringe to re-enter a vial, because reused equipment is a known route for transmitting infection (CDC, 2024). Disinfect the rubber vial septum before each piercing - the rubber top is the doorway into a sterile vial (WHO, 2010). The route you use is a prescriber decision based on the drug and the person; this page covers the measurement and handling side, not who should use which route.
IM vs SubQ: the comparison that matters
The four practical differences are needle length, site, comfortable maximum volume, and absorption speed. The table below summarises typical ranges used in practice - your prescriber and the product label set the actual values.
| Factor | Intramuscular (IM) | Subcutaneous (SubQ) |
|---|---|---|
| Needle length | 25-38 mm (1-1.5 in) | 4-8 mm (3/16-5/16 in) |
| Needle gauge | 22-25 G (drawing often 18-21 G) | 27-31 G (insulin-style) |
| Angle | 90 degrees | 45-90 degrees |
| Typical site | Glute, ventrogluteal, thigh, deltoid | Abdomen, love handles, outer thigh |
| Comfortable max volume | Up to ~3 mL (large muscle) | Up to ~1 mL per site |
| Absorption | Faster (muscle is vascular) | Slower, steadier |
| Common uses | Oil-based testosterone, vaccines | GLP-1s, peptides, HCG, insulin |
Absorption rate is why some clinicians prefer one route over the other. Muscle has a richer blood supply, so an IM oil depot of testosterone releases over days to weeks depending on the ester. A SubQ depot in fat releases more slowly. A pilot study comparing the two routes for testosterone found comparable total exposure (similar AUC) with SubQ being better tolerated by patients (Wilson et al., 2018).
How the route affects the draw (it mostly doesn't)
Here is the part beginners get wrong: the route does not change how many units you pull into the syringe. The draw volume is set entirely by two numbers - your prescribed dose and the vial concentration (mg/mL). Whether the needle ends up in muscle or fat afterwards is irrelevant to the milliliters.
What the route does change is whether that calculated volume fits the route comfortably. If the maths gives 1.5 mL and the plan is SubQ, that exceeds the roughly 1 mL a single SubQ site holds comfortably, so the dose may be split across two sites or sessions on prescriber advice. The same 1.5 mL into a large glute muscle is unremarkable. So the workflow is: calculate the volume, then check it against the comfortable maximum for the chosen route.
How this is calculated
The core formula never changes with route:
volume (mL) = dose ÷ concentration, then U-100 units = mL × 100
So 100 mg of testosterone at 200 mg/mL is 100 ÷ 200 = 0.5 mL = 50 units, full stop - IM or SubQ. The route only enters the picture afterwards, when you ask whether 0.5 mL suits the site you are using.
Diagram: same draw, two depths
Worked examples
Dose 100 mg, vial 200 mg/mL. 100 ÷ 200 = 0.5 mL.
0.5 mL = 50 units. Identical whether injected IM or SubQ.
Same 100 mg dose, but now planned SubQ. 100 ÷ 200 is still 0.5 mL.
Still 50 units. The route never touches the arithmetic.
Dose 250 mg at 200 mg/mL gives 250 ÷ 200 = 1.25 mL. SubQ comfortably holds about 1 mL per site.
1.25 mL exceeds the ~1 mL SubQ ceiling; split across two sites or use IM, on prescriber advice.
That same 1.25 mL going into a large glute muscle is well under the ~3 mL IM comfort limit.
1.25 mL = 125 units, no split needed for IM.
Reconstituted vial at 2.5 mg/mL, dose 0.25 mg. 0.25 ÷ 2.5 = 0.10 mL.
0.10 mL = 10 units - tiny volume, ideal for SubQ.
Switch the same 100 mg testosterone dose to a 250 mg/mL vial. 100 ÷ 250 = 0.4 mL.
0.4 mL = 40 units. Concentration moved the volume, not the route.
HCG reconstituted to 1,000 IU/mL, dose 500 IU. 500 ÷ 1,000 = 0.5 mL.
0.5 mL = 50 units, comfortably within the SubQ ceiling.
A 10-unit (0.10 mL) SubQ draw on a 1 mL barrel sits near the bottom mark and is hard to read precisely.
A 0.3 mL syringe spreads 10 units across more visible marks - better for small SubQ doses.
Common mistakes
The biggest mistake is believing the route changes the dose maths. It does not - only your dose and concentration set the milliliters. A second mistake is using an IM-length needle for a SubQ injection (or the reverse), which puts the medication in the wrong layer. A third is ignoring the volume ceiling: forcing 1.5 mL into a single SubQ site is uncomfortable and can affect absorption, whereas the same volume is fine IM.
Route also follows the label. US testosterone cypionate is approved for intramuscular use only and the label states it "should not be given intravenously" (DailyMed). Even though research suggests SubQ testosterone can work, the approved route is a prescriber and label decision, never something to change because the maths happens to fit.
So, what is the difference between IM and SubQ injections?
IM goes into muscle with a longer needle (25-38 mm); SubQ goes into the fat layer with a short needle (4-8 mm). That changes the site, the comfortable maximum volume (roughly 3 mL IM vs 1 mL SubQ), and how quickly the drug absorbs - but it never changes the draw volume, which is always dose divided by concentration. Use the Testosterone (TRT) dose calculator to work out your milliliters and units, then check whether the volume suits the route your prescriber has chosen.
FAQs
What is the difference between IM and SubQ injections?
Does IM vs SubQ change how many units I draw?
Why is the SubQ needle so much shorter than the IM needle?
Can testosterone be injected subcutaneously?
Does the maximum volume differ between the routes?
Sources
- Wilson DM, Kiang TKL, Ensom MHH. Pharmacokinetics, safety, and patient acceptability of subcutaneous versus intramuscular testosterone injection for gender-affirming therapy: A pilot study. Am J Health-Syst Pharm. 2018.
- Centers for Disease Control and Prevention. Safe Injection Practices to Prevent Transmission of Infections to Patients. CDC, 2024.
- World Health Organization. WHO best practices for injections and related procedures toolkit. WHO, 2010.
- Testosterone Cypionate Injection - prescribing information (intramuscular use only). DailyMed label.
This guide is for general educational purposes only and does not constitute medical advice. The injection route, needle, dose and site must come from your prescriber and the product label. Always verify before injecting.